#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16202	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2212	728.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1812	1812	T	853	T,C,A	624,175,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16202	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2212	728.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1546	1546	C	944	C	895	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16202	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2212	728.9	0	HET	.	.	.	C207T	.	207	207	C	569	569	C	869	C,T	635,169	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16202	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2212	728.9	0	HET	.	.	.	A658G	.	658	658	A	1020	1020	A	955	A,G	685,227	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29238	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3643	800.5	0	.	n	.	0	T695C	SNP	695	695	T	1131	1131	C	858	C	808	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29238	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3643	800.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2074	2074	G	912	G,A	864,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29238	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3643	800.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2407	2407	C	947	C	904	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29238	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3643	800.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2481	2481	A	937	A	894	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29238	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3643	800.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3033	3033	C	923	C	878	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2132	folP	855	855	100.0	folP.l15.c4.ctg.1	1546	136.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1005	1007	AGC	234;236;234	A;G;C	222;222;219	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5776	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3471	166.0	1	SNP	p	S91F	1	.	.	271	273	TTC	608	610	TTC	216;216;216	T;T,C;C	206;203,1;206	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5776	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3471	166.0	1	SNP	p	G95N	0	.	.	283	285	GGC	620	622	GGC	198;196;195	G;G,A;C	186;182,1;182	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5776	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3471	166.0	1	SNP	p	D95G	1	.	.	283	285	GGC	620	622	GGC	198;196;195	G;G,A;C	186;182,1;182	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1768	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1513	116.6	1	SNP	p	G45D	0	.	.	133	135	GGC	499	501	GGC	208;208;210	G;G;C	192;198;197	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	912	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1096	83.1	0	.	n	.	0	A197.	DEL	197	197	A	598	598	A	229	A	217	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6276	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	211.9	1	SNP	p	D86N	0	.	.	256	258	GAC	606	608	GAC	276;275;274	G;A;C	258;250;259	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6276	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	211.9	1	SNP	p	S87R	1	.	.	259	261	CGT	609	611	CGT	275;272;275	C;G;T	263;258;256	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6276	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	211.9	1	SNP	p	R87W	0	.	.	259	261	CGT	609	611	CGT	275;272;275	C;G;T	263;258;256	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6276	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	211.9	1	SNP	p	R87I	0	.	.	259	261	CGT	609	611	CGT	275;272;275	C;G;T	263;258;256	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6276	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	211.9	1	SNP	p	S88P	0	.	.	262	264	TCC	612	614	TCC	273;273;271	T;C,A;C	254;254,1;256	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4486	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2725	164.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1584	1586	GGC	246;243;244	G;G;C	233;230;232	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1254	1256	GCC	191;192;193	G;C;C	187;190;190	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1257	1259	ATG	192;193;193	A;T;G	190;189;190	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1269	1271	ACC	201;201;204	A;C;C	194;194;198	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1269	1271	ACC	201;201;204	A;C;C	194;194;198	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1770	1772	ACC	225;223;223	A,T;C;C	209,1;213;213	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1824	1826	GCG	235;235;238	G;C;G	218;218;223	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1824	1826	GCG	235;235;238	G;C;G	218;218;223	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1947	1949	GGT	215;212;213	G;G;T	200;195;195	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1956	1958	AGC	196;197;198	A;G;C	181;184;183	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4456	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2392	185.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1974	1976	CCG	162;163;163	C,G;C,G;G,A	129,5;128,1;129,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6426	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3073	208.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1589	1591	CCG	241;242;238	C;C;G	218;227;217	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2708	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1738	154.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	446	446	C	178	C	166	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3134	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1705	183.0	1	SNP	p	G120K	1	.	.	358	360	AAG	698	700	AAG	258;256;258	A;A;G	244;243;245	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3134	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1705	183.0	1	SNP	p	N121D	0	.	.	361	363	AAC	701	703	AAC	256;253;251	A;A;C	246;242;240	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3134	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1705	183.0	1	SNP	p	A121N	1	.	.	361	363	AAC	701	703	AAC	256;253;251	A;A;C	246;242;240	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11560	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4830	238.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1286	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1190	107.5	1	SNP	p	V57M	1	.	.	169	171	ATG	612	614	ATG	236;231;232	A;T;G	225;220;221	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
